Shambavi Richard

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Multiple Myeloma

Newly Diagnosed

Top Venues

American journal of hematology

Blood cancer discovery

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Santiago Thibaud, Ryan L Subaran, Scott Newman, Alessandro Lagana, David T Melnekoff, Saoirse Bodnar, Meghana Ram, Zachry Soens, William Genthe, Tehilla E Brander, Tarek H Mouhieddine, Oliver Van Oekelen, Jane Houldsworth, Hearn Jay Cho, Shambavi Richard, Joshua Richter, Cesar Rodriguez, Adriana Rossi, Larysa J Sanchez, Ajai Chari, Erin Laverne Moshier, Sundar Jagannath, Samir S Parekh, Kenan Onel
Multiple Myeloma Risk and Outcomes are Associated with Pathogenic Germline Variants in DNA Repair Genes. Blood cancer discovery (2024)
Shambavi Richard, Alexander M Lesokhin, Barry Paul, Jonathan L Kaufman, Matthew Pianko, Noa Biran, Ravi Vij, Deon B Doxie, Maryam I Azeem, Mercedes Martillo, Katie Wozniak, Hearn J Cho, Kavita M Dhodapkar, Madhav V Dhodapkar
Clinical response and pathway-specific correlates following TIGIT-LAG3 blockade in myeloma: the MyCheckpoint randomized clinical trial. Nature cancer (2024)
Guido Lancman, Kian Parsa, Krzysztof Kotlarz, Lisa Avery, Alaina Lurie, Alex Lieberman-Cribbin, Hearn Jay Cho, Samir S Parekh, Shambavi Richard, Joshua Richter, Cesar Rodriguez, Adriana Rossi, Larysa J Sanchez, Santiago Thibaud, Sundar Jagannath, Ajai Chari
IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies. Blood cancer discovery (2023)
Guido Lancman, Erin Moshier, Hearn Jay Cho, Samir Parekh, Shambavi Richard, Joshua Richter, Cesar Rodriguez, Adriana Rossi, Larysa Sanchez, Sundar Jagannath, Ajai Chari
Trial designs and endpoints for immune therapies in multiple myeloma. American journal of hematology (2022)
Shambavi Richard, Ajai Chari, Sosana Delimpasi, Maryana Simonova, Ivan Spicka, Ludek Pour, Iryna Kriachok, Meletios- Athanasios Dimopoulos, Halyna Pylypenko, Holger W Auner, Xavier Leleu, Ganna Usenko, Roman Hajek, Reuben Benjamin, Tuphan Kanti Dolai, Dinesh Kumar Sinha, Christopher P Venner, Mamta Garg, Don Ambrose Stevens, Hang Quach, Sundar Jagannath, Phillipe Moreau, Moshe Levy, Ashraf Badros, Larry D Anderson, Nizar J Bahlis, Thierry Facon, Maria Victoria Mateos, Michele Cavo, Hua Chang, Yosef Landesman, Yi Chai, Melina Arazy, Jatin Shah, Sharon Shacham, Michael G Kauffman, Sebastian Grosicki, Paul G Richardson
Selinexor, bortezomib, and dexamethasone versus bortezomib and dexamethasone in previously treated multiple myeloma: Outcomes by cytogenetic risk. American journal of hematology 96 (9) (2021)
Sherry Bhalla, David T Melnekoff, Adolfo Aleman, Violetta V Leshchenko, Paula Restrepo, Jonathan J Keats, Kenan Onel, Jeffrey R Sawyer, Deepu Madduri, Joshua Richter, Shambavi Richard, Ajai Chari, Hearn Jay Cho, Joel T Dudley, Sundar Jagannath, Alessandro Lagana, Samir S Parekh
Patient similarity network of newly diagnosed multiple myeloma identifies patient subgroups with distinct genetic features and clinical implications. Science advances 7 (47) (2021)